What is the most exciting, important, promising, all-around awesome stem cell biotech of 2014? Vote and tell us why in the comments.
I’ve added a fun and helpful new feature on the right side bar of the blog in the form of a stock ticker for some of the most widely held stem and cellular medicine companies. A sample screen shot is […]
The Australian stem cell biotech Mesoblast (MSB) has reportedly reached a deal with the American stem cell biotech Osiris (OSIR) to buy Osiris’ mesenchymal stem cell (MSC) unit. This is a big development in the MSC field. Osiris and Mesoblast are […]